1. Home
  2. Health
  3. Arthritis
Carol & Richard Eustice
Arthritis Blog

By Carol & Richard Eustice, About.com Guides to Arthritis

Rheumatoid Arthritis Cure - Within Our Reach

Thursday July 19, 2007
Rheumatoid arthritis affects over 2.1 million Americans. Advances have been made with regard to understanding the disease and treating it, but there is still no cure. Early diagnosis and early treatment are considered essential to keep rheumatoid arthritis patients as active and productive as possible. Rheumatoid arthritis treatments have improved dramatically over the past decade.

Rheumatoid arthritis costs society more than $80 billion every year. Research dollars for rheumatoid arthritis average $25.90 per patient, which is significantly lower than other chronic diseases such as lupus, diabetes, and multiple sclerosis which average $330 per patient. Despite low funding for research, the significant progress being made highlights the need for more financial support for rheumatoid arthritis research.

The American College of Rheumatology Research and Education Foundation has launched a campaign, called Within Our Reach: Finding a Cure for Rheumatoid Arthritis. The campaign is a national, multi-year fundraising program with a goal of raising $30 million for rheumatoid arthritis research. The huge fundraising effort has already received support from the pharmaceutical industry, biotech companies, doctors, and patients. More information about Within Our Reach is available on their website.

More Related Resources:

Photo by James Gathany (PHIL)

Comments

No comments yet. Leave a Comment

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Explore Arthritis
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

  1. Home
  2. Health
  3. Arthritis

©2009 About.com, a part of The New York Times Company.

All rights reserved.